Antonia S, et al. Overall survival with durvalumab versus placebo after chemoradiotherapy in stage III NSCLC: updated results from PACIFIC. IASLC 2018, abstract PL02.01.
“Een arts op TikTok bereikt jongeren via hun leefwereld”
apr 2024 | Longoncologie